Cytarabine Hydrochloride: A Key Pharmaceutical Intermediate for Leukemia Treatment
Discover the essential role of Cytarabine Hydrochloride in combating leukemia and advancing cancer therapies.
Get a Quote & SampleProduct Core Value
Cytarabine Hydrochloride
Cytarabine Hydrochloride is a vital pharmaceutical intermediate, recognized for its potent antileukemic properties. It functions by interfering with DNA replication, making it a cornerstone in the treatment of various types of leukemia, including acute myeloid leukemia (AML) and acute lymphocytic leukemia (ALL).
- This high purity Cytarabine Hydrochloride (>99%) is crucial for effective leukemia treatment, ensuring the efficacy of the final drug formulation.
- The mechanism of action involves inhibiting DNA synthesis, directly targeting cancer cells and halting their proliferation.
- Backed by certifications like GMP, HSE, ISO 9001, USP, and BP, it signifies a commitment to quality and safety in pharmaceutical manufacturing.
- As a key pharmaceutical intermediate for leukemia treatment, its consistent availability and quality are paramount for drug manufacturers worldwide.
Key Advantages
Uncompromised Purity
Achieve superior therapeutic outcomes with our high purity Cytarabine Hydrochloride (>99%), ensuring minimal impurities and maximum efficacy in your formulations.
Certified Quality Assurance
Rely on our stringent quality control, evidenced by GMP, HSE, ISO 9001, USP, and BP certifications, guaranteeing a pharmaceutical intermediate for leukemia treatment that meets global standards.
Reliable Supply Chain
Benefit from a consistent and dependable supply of Cytarabine HCl powder, supporting your production needs without interruption for your chemotherapy drug development.
Key Applications
Acute Myeloid Leukemia (AML) Treatment
Cytarabine Hydrochloride is a primary component in regimens targeting AML, playing a critical role in reducing leukemia cell counts and achieving remission.
Acute Lymphocytic Leukemia (ALL) Therapy
Its antimetabolite properties are essential for treating ALL, disrupting cancer cell DNA synthesis and aiding in patient recovery.
Chronic Myelogenous Leukemia (CML) Support
While other treatments exist, Cytarabine Hydrochloride can be part of comprehensive strategies for managing CML, contributing to disease control.
DNA Synthesis Inhibition in Oncology
As a potent inhibitor of DNA synthesis, it serves as a crucial intermediate for developing advanced antineoplastic agents.
Related Technical Articles & Resources
Why Choose Us?
Leverage our expertise and state-of-the-art infrastructure to accelerate your journey from discovery to commercial success.
Global Experience
With 20 years of R&D, manufacturing, and sales experience, we proudly serve clients across 60 countries and regions worldwide.
Advanced Facilities
Our in-house R&D laboratory, pilot platform, and large-scale production workshop are equipped to meet the audit requirements of global customers.
Seamless Scalability
We facilitate a perfect transition from small-scale lab requirements (grams) to full commercialization (hundreds of tons).